Convenient Oral Dissolving Film
doi:10.20517/cdr.2018.08 24 Minich DM, Brown BI
Barton (2014) Optimizing IGF-I for skeletal muscle therapeutics Growth Hormone & IGF Research, Volume 24, Issue 5, October 2014, Pages 157-163
On the actions of the growth hormone-releasing hexapeptide, GHRP
Stakeholders in the compounding supply chain should monitor these developments closely and consider proactive engagement with API suppliers to ensure readiness
Looking Ahead What Sponsors Should Prepare For in 2026 Expect stronger focus on: Adaptive and Decentralized Trial Designs (DCTs) Digital endpoints and real-world evidence Inclusive recruitment strategies Clear dose-optimization rationale, especially in oncology At Tigermed EMEA, we continue to invest in innovative operational models, digital ecosystems, and regulatory intelligence to ensure our partners stay ahead of evolving global requirements.